Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand’s disease (VWD) has limited value in dosing for surgery-Reference-Cited by-同舟云学术

Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand’s disease (VWD) has limited value in dosing for surgery

Published:2011-06 Issue: Volume: Page:no-no
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

DI PAOLA J.,LETHAGEN S.,GILL J.,MANNUCCI P.,MANCO-JOHNSON M.,BERNSTEIN J.,NICHOLS W. L.,BERGMAN G. E.

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2011.02583.x/fullpdf

Reference18 articles.

1. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis;Sadler;Thromb Haemost,1994

2. Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P);Thompson;Haemophilia,2004

3. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P);Michiels;Blood Coagul Fibrinolysis,2004

4. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study;Mannucci;Blood,2002

5. Clinical use of Haemate P in inherited von Willebrand’s disease: a cohort study on 100 Italian patients;Federici;Haematologica,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what’s new on the horizon?;Expert Opinion on Pharmacotherapy;2024-07-23

2. Diagnosis and treatment of von Willebrand disease in 2024 and beyond;Haemophilia;2024-03-13

3. Perioperative hemostasis management in patients with von Willebrand disease: an institutional experience;Blood Coagulation & Fibrinolysis;2023-12-20

4. The road to implementation of pharmacokinetic-guided dosing of factor replacement therapy in hemophilia and allied bleeding disorders. Identifying knowledge gaps by mapping barriers and facilitators;Blood Reviews;2023-09

5. Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease;Blood Advances;2021-03-08